Kalvista Pharmaceuticals Inc (KALV) — Capital Reinvestment Ratio
Kalvista Pharmaceuticals Inc (KALV) has a Capital Reinvestment Ratio of 0.01x as of January 2018, meaning it reinvests 0% of its operating cash flow ($28.22 Million) in capital expenditures ($182.00K). See KALV equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Kalvista Pharmaceuticals Inc Capital Reinvestment Ratio (2018–2018)
This chart tracks Kalvista Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. Check cash flow reinvestment rate of Kalvista Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Kalvista Pharmaceuticals Inc (2018–2018)
Year-by-year Capital Reinvestment Ratio for Kalvista Pharmaceuticals Inc from 2018 to 2018. For live market cap and broader valuation context, see Kalvista Pharmaceuticals Inc (KALV) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2018 | 0.14x | $10.56 Million | $1.43 Million | — |